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Objective: This study evaluates the efficacy of bovine peritoneum/fascia as an arterial substitute.
Methods and Outcome Measures: Twelve dogs underwent bilateral femoral artery patch angioplasty with a glutaraldehyde-
fixed bovine peritoneal/fascial patch (PFA patch) on one side and polyester patch on the contralateral side. Arteriograms
were performed just before vessel harvest at 1 and 6 months, and vessels were evaluated for aneurysms and inflammation.
Histologic analysis included intima area, media thickness, and lumen area. Immunofluoresence for CD 34 and Factor
VIII was done to evaluate endothelialization and -actin for smooth muscle cell growth. Mechanical strength testing was
evaluated in separate PFA patches and compared independently to a commercially available bovine pericardial patch and
polyester patch.
Results: All vessels examined at both 1 and 6 months were patent with no arteriographic evidence of stenosis. There was
no evidence of aneurysm formation in any vessel and no difference between groups in inflammatory reaction. One
polyester patch at 1 month developed an infection. Microscopic evaluation of experimental vessels revealed no difference
between groups in intima area at 1 month (2.1  1.2 vs 2.2  1.2 mm2; P  .5) and at 6 months (1.81  1.2 vs 1.9 
1.2 mm2; P  .5). There was no difference in media thickness, but the PFA patch group had a greater lumen area at 1
month (8.8  2.9 vs 9.8  3.0 mm2; P  .02) and 6 months (10.5  4.2 vs 11.7  5.6 mm2; P  .02).
Immunofluoresence for CD34 and Factor VIII demonstrated complete re-endothelialization of all patches. The polyester
patch had a chronic inflammatory response, but not the PFA patch. Mechanical strength testing demonstrated that
compared to pericardium, the PFA patch had superior (P < .05) failure tension, stiffness, and suture pullout strength,
whereas extensibility, fatigue tension, relax slope, and creep tests were not different. Polyester demonstrated superior
suture pullout, stiffness, relax slope, and failure strain (P < .05), but it was not different in failure tension and
extensibility than the PFA patch. However, the PFA patch had significantly less creep (0.25  0.25 vs 4.92  0.84; P <
.01).
Conclusions: The PFA patch has similar clot-resistant properties to polyester and is superior to the pericardial patch in
mechanical strength. It is a promising endothelial alternative for not only arterial patches but other vascular products.
( J Vasc Surg 2005;41:490-7.)
Clinical Relevance: The search for an artificial, thromboresistant, and intimal hyperplasia resistant interface between
blood and native blood vessels still continues. This study demonstrates the feasibility and proof of concept of the
peritoneum’s clot-resistant properties. When adding the underlying fascia, it serves as an ideal arterial patch. Other
studies are underway evaluating its feasibility as a bypass graft and a “drug coated”–like stent lining.Polyester (Dacron) and expanded polytetrafluoroethyl-
ene are the mainstay arterial substitutes for open vascular
surgical procedures. Biologic substitutes such as bovine
pericardial patches, bovine carotid arteries, and human
umbilical vein grafts are other alternatives, but they have
not gained widespread acceptance. Cadaveric arteries and
veins have shown promise,1 but their long-term durability
is suspect, and their costs are prohibitive.
Although blood vessel substitutes have drawn consid-
erable attention, their genesis stems from simpler patches.
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490Arterial patches have been in use since Dos Santos first
described thromboendarterectomy,2 and polyester and au-
tologous vein are the primary choices for arterial patches
after carotid endarterectomy.3 Nonetheless, bovine peri-
cardium has been widely used as an interface between blood
and tissue for heart valves, and there has been a recent
report of excellent long-term results using bovine pericar-
dial patches for carotid endarterectomy.4 Tissue has been
promoted for use as arterial and venous substitutes because
of less chance of infection5 and potentially less restenosis.6
Despite these potential benefits, quantity, size, and dura-
bility for use as dialysis and bypass grafts or other arterial
applications have been suboptimal. Similarly, prosthetic
bypass grafts also have inferior results with high levels of
restenosis and inferior patency rates.7
The optimal arterial substitute has not been found.
With limited autogenous vein and poor results of prosthetic
arterial substitutes, alternative sources of materials continue
to be explored. Peritoneum is the abdominal cavity’s em-
bryologic equivalent to endothelium, because it is derived
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pleura in its surface characteristics and functions as “fric-
tionless” interface for visceral surfaces. The following study
reports the use of bovine peritoneum with adherent fascia
as a novel source for arterial placement.
MATERIAL AND METHODS
Bovine peritoneal/fascia patch tissue harvest and
processing. All studies were conducted under Good Lab-
oratory Practice conditions, were approved by the animal
review committee, and were performed in accordance with
institutional guidelines and the Guide for the Care and Use
of Laboratory Animals.8 Bovine weighing between 125 and
130 kg (Robert Mikesell Stock Farm, Frazeysburg, Ohio)
were quarantined for a minimum of 3 days; food was
withheld for 8 to 12 hours and water for 2 hours before
each procedure. Each bovine received benzathine-procaine
penicillin (30,000 to 50,000 U/kg intramuscular) preop-
eratively followed by sedation to deliver isoflurane (2% to
4%). The animals were intubated, and anesthesia was main-
tained with isoflurane (0.8% to 1.25%). The animal’s abdo-
men and chest were scrubbed with alcohol and betadine,
and a longitudinal abdominal incision and two upper and
lower abdominal transverse incisions were made to expose
the peritoneum/fascia (PFA). The PFA was extracted for
tissue processing, and the animal was killed.
After the tissue was harvested, it was placed in a con-
tainer with 0.9% phosphate buffered saline (PBS; Baxter
Healthcare Corporation, Deerfield, Ill) at pH 7.4 and
temperature 4.0°C. The tissue was cut into segments,
sutured to polyethylene plates, and placed into sterile jars.
Further processing for cross-linking and sterilization was
done in the following manner. The PFA fixed on the plate
was bathed in PBS at room temperature for 1 hour. Next,
the tissue was cross-linked by transferring it to 2.5% glutar-
aldehyde solution (Fisher Scientific, Fairlawn, NJ) for 24
hours. It was then rinsed in PBS for 1 hour and sterilized in
50% reagent ethanol (Labchem Inc, Pittsburgh, Pa) for 24
hours. Subsequent inactivation of prions was done in 1
molar NaOH for 2 hours9 after rinsing in PBS. The tissue
underwent a final rinse in PBS before placing it into its final
storage solution of 0.625% glutaraldehyde.
Experimental procedure. Female random source
dogs weighing between 25 to 30 kg (Hodgins Kennels,
Inc, Howell, Mich) were housed in individual cages in
light-dark–cycled, temperature-controlled rooms. Stan-
dard food and tap water were offered ad libitum. The
canines were quarantined for a minimum of 7 days, and
animals were kept without food for 8 to 12 hours and water
for 2 hours preceding each procedure. Animals were anes-
thetized with sodium thiopental (16 to 20 mg/kg, intra-
venous), intubated, and maintained with 1.5% isoflurane.
Each animal received benzathine-procanine pencillin
(450,000 U, intramuscular). Femoral regions were
prepped and draped in sterile fashion.
Twelve dogs underwent bilateral femoral artery expo-
sure. Before implanting the PFA patch, each patch wasrinsed in PBS solution for 5 minutes. The animal was
heparinized (80 U/kg), and activated clotting time (ACT)
was obtained at 3 minutes; additional heparin administra-
tion ensured adequate anticoagulation to maintain the
ACT 2 1/2 times the baseline. Patch angioplasty was done
by sewing a 0.8 3 cmPFA patch on one side and a control
polyester patch of similar dimensions on the contralateral
side (Hemashield; Boston Scientific, Oakland, NJ) with a
continuous 6-0 polyprolene suture (Ethicon, Somerville,
NJ). Each animal served as its own control, and left and
right sides were alternated. All incisions were closed with
2-0 vicryl sutures (Ethicon). Animals were given buprenor-
phine (0.01 to 0.02 mg/kg, subcutaneous, twice a day) for
postoperative discomfort. Dog’s femoral arteries were eval-
uated for blood vessel patency daily for the first week and
then weekly thereafter. End points for vessel harvest were 1
month and 6 months.
Vessel harvest. One half of the canines were killed at 1
month and the other half at 6 months. The animals were
heparinzed (80 U/kg), and each dog was anesthetized as
described above. The right common carotid artery was ex-
posed for arteriographic access, and bi-planar arteriography
was taken by using an OEC 9600 C-arm (GE Medical Sys-
temsOEC, Salt LakeCity,Utah) in the anterior-posterior and
lateral views by injecting 10 mL of intravenous contrast
(Hypaque-76; Amersham Health, Princeton, NJ). Patency
along with degree of stenosis was documented. After the
arteriograms were obtained, the experimental vessels were
exposed, and gross evaluation was performed to determine
aneurysm formation and inflammation. Inflammation and
adhesionswere recorded for each vessel by the following scale:
1, mild; 2, mild-moderate; 3, moderate; 4, moderate-severe;
5, severe. Each vessel was harvested after pressure perfusion
fixation at 120 mm Hg as previously described.10 Two liters of
PBS and 1 L of 2.5% glutaraldehyde were perfused through
each vessel. Each study vesselwas harvested2 cmproximal and
distal to each patch and stored in 2.5% glutaraldehyde until
histologic processing.
Histologic processing. Representative sections of
each artery were obtained at 1.0-cm intervals from the
proximal, mid, and distal portions of the vessel and labeled.
All tissue sections were dehydrated in a graded series of
ethanol and embedded in paraffin. Sections were cut at 4 to
6 m, mounted, and stained with hematoxylin-eosin and
Movat’s Pentachrome. Each cross-section was further di-
vided into four quadrants. The patch was at 12 o’clock, and
in a clockwise formation labeling the next three quadrants
were 3, 6, and 9 o’clock. All four quadrants were measured
for intimal thickness, quadrant 6 o’clock was measured for
medial thickness, and quadrant 12 o’clock was measured
for graft thickness. Lumen area was calculated by measur-
ing by internal elastic lamina in native artery (from 3 o’clock
to 9 o’clock) and interface between graft and neointima in
graft area (from 9 to 3 o’clock). Total vessel area was
determined by measuring the interface between the graft
and surrounding external elastic soft tissue between 9 and 3
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to 3 o’clock. Intima/vessel wall ratio was defined as [IL
area – L area]/[TVA – IL area].
For immunofluoresence, sections were deparaffinized
and rehydrated before being microwaved in 10 mmol/L
citrate buffer (pH 6.0) for 15 minutes to achieve antigen
retrieval. The tissue was blocked in 3% bovine serum albu-
min for 30 minutes at room temperature and washed three
times in PBS. Primary antibodies were applied to recognize
smooth muscle -actin (mouse monoclonal antibody,
clone 1A-4), CD34 (mouse monoclonal antibody, clone
Ab-1), and Factor VIII (rabbit polyclonal antibody) in the
concentration of 1 g/mL for the monoclonal antibodies
and 1:80 dilution for the polyclonal antibody. All primary
antibodies were purchased from Neomarkers Inc, Fre-
mount, Calif. After washing in PBS four times, fluorescein
isothiocyanate–tagged secondary antibodies were applied
(Santa Cruz Biotechnology Inc, Santa Cruz, Calif). Rabbit
anti-mouse immunoglobulin G (IgG) was applied to sec-
tions stained for smooth muscle actin and CD34 at 5g/
mL, and 5g/mL of goat anti-rabbit IgG was used on
Factor VIII sections. Negative control sections were
stained with secondary antibodies alone. For each antibody
two sections from each time point of 30 and 180 days in
both groups of washed and unwashed were stained. Slides
were analyzed with Leica Qwin system (Leica, Wetzlan,
Germany) by using Image Pro Plus 5.0 software (Media
Cybernetics, Silver Spring, Md).
Mechanical testing. Specimens were compared to a
commercially available bovine pericardial patch (Vascu-
guard; Synovis Life Technologies, St Paul, Minn). Strips of
peritoneum with adherent fascia were cut along the princi-
pal collagen fiber direction. Mechanical tests were per-
formed by using an Instron 8511 series hydraulic testing
frame outfitted with a 22-kg or 11-kg load-cell (Sensotec,
Insron; Canton, Mass). All tests were performed in a saline
bath heated to 37°C. Tissues were held with delrin clamps
(Acetal; Dupont, Wilmington, Del) lined with sandpaper.
Propriety software was used for control of the load frame
and acquisition of load and displacement data. Preliminary
testing demonstrated that a load of 1000 g was well within
the linear range of the load displacement curve of the
bovine PFA and the pericardial patch and thus suitable for
the tensile tests. Tensile tests were conducted at a ramp rate
of 4 mm/s up to a load of 1000 g. Each specimen was
preconditioned for 10 cycles. This was immediately fol-
lowed by an elongation test, then by a 100-second stress
relaxation test, and finally a failure test. All data were
sampled at 200 Hz.
The loads used for each group in the creep test were
approximately 20% of the mean failure load for that group
as measured in the tensile tests. The bovine PFA was loaded
to 1000 g, whereas the pericardium and the Vascuguard
specimens were loaded to approximately 450 g. Each spec-
imen was preconditioned for 10 cycles at 4 mm/s and then
loaded to 1000 g and held at 1000 g for 1 hour. Data were
sampled at 200 Hz for the preconditioning cycles and 10
Hz for the creep test.During the first suture pullout test, 6-0 prolene suture
failed at roughly 700 g and did not affect the tissue. We
then switched to a wire suture less than 1 mm in diameter.
The specimen was placed so that 2 mm of its length was
inside the grip. The suture was than passed through the
tissue approximately 2 to 3 mm from the free edge, held at
the top, and pulled at 4 mm/s so that the suture would pull
perpendicular to the collagen fiber direction. The wire
suture did pull through the tissue. Data were collected at
400 Hz.
For mechanical testing, load and displacement data
from the elongation and failure tests were converted to
tension (load in newtons divided by width in meters) and
strain, respectively. The tension versus strain curves were
then fit with an exponential function in the toe region and
a cubic function in the linear region. From these curves we
measured extensibility, stiffness, and failure tensions and
strains. The load data from the stress relaxation test were
also converted to tension and plotted versus log (time s).
The data were fit with a line, and the slope of the line was
calculated and reported as the stress relaxation slope. The
creep data were plotted as % strain vs time in seconds. The
total strain required to maintain the creep load was calcu-
lated by subtracting the strain at 60 seconds from the strain
at 3600 seconds. The long-term creep rate was calculated
by taking the slope of a line fitted to the strain vs time plot
from 60 to 3600 seconds. Suture pullout strength was
measured as the ultimate load (g) recorded as the wire
suture was pulled through the tissue.
Statistical comparisons were conducted with the 2
test, Fisher exact test, and paired t test where appropriate.
All values represent mean  SD.
RESULTS
Animal experimentation. All animals had palpable
femoral pulses at the time of harvest. There was no aneu-
rysm formation, adhesions, and inflammation in either test
or control arterial patch. One animal at 1 month developed
an infected polyester patch, and no animal in the PFA
group developed an infection. Representative angiograms
at both 1 and 6 months are shown in Fig 1. All vessels were
patent with no evidence of significant stenosis in both the
experimental and control groups at both time periods.
Histology. Morphometric histologic evaluation of
the vessels is presented in Table I. There was no difference
between groups in media thickness or total vessel area at
both time periods. There was minimal neointimal hyper-
plasia in both groups at 1 and 6 months (Fig 2). The
neointima area was significantly greater in the polyester
patch than in the PFA patch at 1 month (2.05  1.29 vs
1.81 0.74 mm2; P .01), but there was no difference at
6 months (2.60  1.07 vs 2.42  1.13 mm2; P  .50).
Lumen area was significantly greater in the PFA patch
group at both 1 month (6.91 2.46 vs 6.01 2.34 mm2;
P .02) and 6 months (11.51 7.1 vs 10.5 2.91 mm2;
P  .01). In addition, chronic inflammatory cells such as
lymphocytes, macrophages, and multinucleated giant cells
were present between the polyester fibers at both 30 and
or a
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within the PFA patch (Fig 3). Immunohistochemistry
staining for CD 34, Factor VIII, and actin is shown in Fig 4.
Both the PFA patch and the polyester patch stained the
luminal surface heavily with CD34 and Factor VIII at 1 and
6 months in both groups. Immunofluoresence for -actin
was quantified by counting five high-power fields (400)
in both groups at 30 and 180 days and three separate
specimens. There was twice the quantity of smooth muscle
cells at 180 days compared to 30 days, but there was no
difference between the PFA patch and polyester patch at
each time point.
Mechanical properties. Results from the tensile tests
are summarized in Tables II and III. Compared to the
pericardial patch, the PFA patch displayed significantly
greater stiffness (60.6  10.5 vs 28.5  17 kN/m; P 
.002). In addition, the PFA patch failed at significantly
higher failure tensions than the pericardial patch (8.8 2.2
vs 4.2 2.6 kN/m; P .004) and had a greater relax slope
(5.2 0.6 vs 3.1 0.1 N/m/log s; P .001). Finally, the
PFA patch exhibited much greater suture pullout strength
than the pericardial patch (3.1  1.6 vs 1.3  0.3 kg; P 
.05). There was no difference between the PFA patch and
the pericardial patch for failure strain and extensibility (P
not significant). We also compared the PFA patch to the
Fig 1. Lateral (A) and anterior/posterior (B) arteriog
demonstrating patent vessel with no evidence of stenosis
Table I. Histologic morphometric measurements
30 Days
PFA patch Polyester patch
Medial thickness 0.29  0.09 0.28  0.08
Intimal area 1.81  0.74 2.05  1.29
Lumen area 6.91  2.46 6.01  2.34
Total vessel area 19.12  5.3 21.02  7.79
All values are mm2, mean  standard deviation.polyester patch for mechanical properties (Table III). Poly-ester demonstrated superior suture pullout, stiffness, relax
slope, and failure strain, but it was not different in extensi-
bility and failure tension. All groups had the same total
amount of creep during 1 hour when loaded to approxi-
mately 20% of their failure strength. Most of the creep
occurred during the first 10 minutes of the test. During the
last 50 minutes the PFA patch and pericardial patch did not
creep (0.3  0.1 vs 0.3  0.1% strain/h; P  not signifi-
cant). However, the polyester patch continued to creep
(4.9  0.8 vs 0.3  0.3% strain/h; P  .01).
DISCUSSION
Peritoneal tissue was first used in the early 1970s by
Polish researchers as a graft material to repair the inner
lining of blood vessels.11 In these preliminary experiments,
peritoneal tissue was placed on the inside of conventional
polyester grafts and produced superior results in the canine
aorta compared to controls. Grafts implanted with perito-
neum remained patent for a longer period of time than
polyester alone. Other researchers have demonstrated the
tissue’s effectiveness in the venous circulation as a patch and
graft in the inferior vena cava.12,13 Further work has fo-
cused on using the peritoneum itself as a bypass in blood
vessels that supply the peripheral circulation; however, the
of femoral artery containing PFA patch at 6 months
neurysm.
180 Days
value PFA patch Polyester patch P value
.35 0.16  0.04 0.17  0.06 .75
.01 2.60  1.07 2.42  1.13 .50
.02 11.51  7.1 10.5  2.91 .01
.09 28.96  9.31 28.14  6.20 .48ramPtissue proved too thin to be used alone.14,15
ue ar
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dothelial cells because the coelomic cavity is designed like a
tube within a tube. Pericardium is a similar tissue that has
been used extensively as valve leaflets for aortic and mitral
valve replacement and also has been used for more than 10
years as an arterial patch for carotid endarterectomy. Its
usefulness in applications as artificial conduit for bypass
grafts and stent linings is limited by its thickness and
quantity. Whereas the PFA patch approaches pericardial
patch in terms of thickness (1.0 vs 1.2 mm), the perito-
neum alone is five times thinner (0.2 mm). The fascia is
composed of primarily collagen, which gives it its strength.
Peritoneum is composed of confluent sheet of mesothelial
cells with an underlying basement membrane. Our data
support the concept that its surface characteristics give it its
thromboresistant properties as it might serve as a scaffold
for re-endothelialization of native cells. Its thin layer makes
it potentially an ideal endothelial substitute for application
in other vascular conduits such as bypass grafts and stents
for which current studies are underway.
We chose the model described in this experiment for
several reasons. The first is that using xenogeneic material
allows for testing of a source of abundant product, and
cross-linking the material eliminates the antigenicity. The
main advantage of using glutaraldehyde and alcohol as a
fixative stems from glutaraldehyde’s ability to cross-link,
Fig 2. Hematoxylyn-eosin sections from 30 days (A an
canine femoral arteries.A andC are the PFA patch, andB
stains similar to native tissue, and the polyester patch (blwhich not only eliminates xenogeic antigens, but also pre-vents enzymatic degradation.16 However, a long-term dis-
advantage is the potential development of mineraliza-
tion.17 Possibly other novel fixatives will alleviate this
problem. In addition, we used the dog model because the
canine femoral artery approaches the size of human carotid
arteries, thus accommodating a typical patch used in clinical
settings. Polyester was used as the in vivo control because it
is the most widely accepted arterial patch and is considered
the gold standard, despite being synthetic.
Mechanical testing of the PFA patch was compared to a
commercially available pericardial patch because it is the
most widely used tissue patch for blood vessels and serves as
a standard for comparison. Mechanical strength testing was
undertaken before implantation to determine whether the
underlying connective tissue could withstand the forces
imposed by continuous pulsatile pressure during long pe-
riods of time. The greater failure tension, stiffness, and relax
slope of the PFA patch compared to the pericardial patch
demonstrate its intrinsic properties that make it an ideal
vessel substitute in terms of its ability to tolerate hemody-
namic forces in the arterial circulation. Suture pullout
strength is the most important basic property that demon-
strates proof of concept for use as an arterial patch, because
of the strength provided by the adherent underlying fascia.
We also compared its strength to a commercially available
polyester patch, and as expected the synthetic polyester
and 180 days (C and D) of arterial patches implanted in
D are the polyester patch. The PFA patch (yellow arrows)
rows) does not take up the stain.d B)
andpatch was stronger in several areas. However, it was some-
arrow
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after a short period of time, and the polyester patch kept
moving. This is likely due to the synthetic nature of the
woven material.
The in vivo results presented in this article are impor-
tant for evaluating the tissue’s ability to withstand con-
tinuous arterial pressure over a length of time and also
act as a template for new endothelial cell repopulation.
In this regard, the PFA patch withstood up to 6 months
of arterial pressure with no aneurysm formation. In
addition, it served as an ideal template for re-endotheli-
alization because there was abundant CD34 and Factor
VIII staining. There was minimal smooth muscle actin
staining at the luminal surface, also complementing the
morphometric assessments that showed minimal neoin-
timal hyperplasia. It is possible that the compliance of the
tissue in addition to its mesothelial-like properties ac-
counted for its ability to resist extensive intimal hyper-
plasia. Another potential advantage of using tissue is that
it elicits minimal inflammation and adhesions, despite
the tissue coming from another species. Fixing the tissue
inactivates the actual peritoneal cell, but the inherent
properties of a confluent surface allow for laminar flow
Fig 3. Hematoxylin-eosin stained sections of the perito
femoral artery model after 180 days. There is severe infla
inflammation is seen within the peritoneal patch. This in
body type, consisting of macrophages, giant cells (blacksimilar to that of heart valves and arterial patches made ofpericardium. More importantly, there was no vessel
thrombosis and less stenosis compared to controls as
demonstrated by the greater lumen area. Although we
did not measure the total length of the patch after
implantation at either the gross or microscopic level,
there was no gross or microscopic evidence of aneurysm
formation. The lumen area of both groups of vessels
increased over time. Despite a greater lumen area, the
overall vessel area and neointimal area were identical in
both groups. It is possible the small but measurable
differences in lumen area at both time periods in the PFA
patch group were from an overall difference in tissue
compliance, a processing area, or a type II error, because
there was no difference in intima area. We could not
measure overall media area, given that the lumen was
interrupted by the patch. However, there were no differ-
ences in media thickness at measurable points.
In conclusion, cross-lined bovine PFA has inherent
strength and thromboresistant properties in vivo that
make it a promising arterial substitute. It acts as a tem-
plate for re-endothelialization and might be a potential
source for artificial endothelial. Current studies are un-
derway evaluating its efficacy in lining stents and as
patch (A) and the polyester patch (B) from the canine
tion between the polyester fibers (green arrow), and no
ation shown under higher power (C) is of the foreign
s), and occasional lymphocytes.neal
mma
flammbypass grafts.
JOURNAL OF VASCULAR SURGERY
March 2005496 Sarac et alREFERENCES
1. Buckley CJ, Abernathy J, Lee SD, Arko FR, Patterson DE, Manning
LG. Suggested treatment protocol for improving patency of femoral-
infrapopliteal cryopreserved saphenous vein allografts. J Vasc Surg
2000;32:731-8.
2. Friedman SG. A history of vascular surgery. Mount Kisko (NY): Futura;
1989. p. 94-6.
3. Hertzer NR, O’Hara PJ, Mascha EJ, Krajewski LP, Sullivan TM, Beven
EG. Early outcome assessment of 2228 consecutive carotid endarterec-
tomy procedures: the Cleveland Clinic experience from 1989 to 1995.
Fig 4. Immunofluoresence staining of patched arteries a
actin (C) in the region overlying the patch.
Table II. Tensile properties of PFA patch vs pericardial pa
Group
Extensibility
(% strain)
Failure strain
(% strain)
F
PFA patch 13.3  2.4 31  4.9
Pericardial patch 12.9  7.6 34.1  6.2
P value NS NS
All values are mean  standard deviation.
NS, Not significant.
Table III. Tensile properties of PFA patch vs polyester
Group
Extensibility
(% strain)
Failure strain
(% strain)
Fail
(
PFA patch 11.2  6.0 27.2  7.5 3
Polyester 18.9  0.7 180.2  6.1 5
P value NS .004
All values are mean  standard deviation.
NS, Not significant.J Vasc Surg 1997;26:1-10.4. Biasi GM, Sternjacob S, Mingazzini BM, Ferrari SA. Nine-year experi-
ence of bovine pericardium patch angioplasty during carotid endarter-
ectomy. J Vasc Surg 2002;36:271-7.
5. Bandalyk SF, Coffey AC, Lantz GC, Tacker WA, Geddes LA. Compar-
ison of the resistance to infection of intestinal submucosal arterial auto
grafts versus polytetrafluoroethylene arterial prosthesis in a dog model.
J Vasc Surg 1994;19:465-72.
6. Tretter JF, Hertzer NR, Mascha EL, O’Hara PJ, Krajewski LP, Beven
EG. Perioperative risk and late outcome of non elective carotid endar-
terectomy. J Vasc Surg 1999;4:30:618-31.
days for Factor VIII (A), CD34 (B), and smoothmuscle
e tension
/m)
Relax slope
(N/m/log s)
Stiffness
(kN/M)
Suture
pullout (g)
 2.2 5.2  0.6 60.6  10.5 3120  1586
 2.6 3.2  0.1 28.5  17.0 1327  267
04 NS .002 .005
nsion
)
Relax slope
(N/m/log s)
Stiffness
(kN/M)
Suture
pullout (g)
2.4 5.6  1.1 27.7  7.5 476  191
0.4 10.8  0.3 11.5  0.4 3116  309
.001 .002 .05t 180tch
ailur
(kN
8.8
4.2
.0ure te
kN/m
.6 
.2 
NS7. Green RM, AbbottWM,Matsumoto T,Wheeler JR,Miller N, Veith FJ,
JOURNAL OF VASCULAR SURGERY
Volume 41, Number 3 Sarac et al 497et al. Prosthetic above-knee femoropopliteal bypass grafting: five-year
results of a randomized trial. J Vasc Surg 2000;31:417-25.
8. Guide for the Care and Use of Laboratory Animals, Institute of Labo-
ratory Animal Resources, Commission on Life Sciences, National Re-
search Council. Washington: National Academy Press; 1996.
9. Taylor DM. Inactivation of prions by physical and chemical means. J
Hosp InfecViral Sterilization 1999:43:S69-76.
10. Sarac TP, Riggs PN, Williams JP, Feins RH, Baggs R, Rubin P, et al.
The effects of low-dose radiation on neointimal hyperplasia. J Vasc Surg
1995;22:17-24.
11. Kubicki B. The formation of internal lining of arterial prosthesis from
free graft of parietal peritoneum in dog. Polish Med J 1971;X:
1031-7.
12. Ribbe EB, Alm P,Hallberg E, Norgen LEH, Bengmark SBS. Peritoneal
tube grafts, PTFE-grafts, and vein grafts in the inferior vena cava of the13. Akimaru K, Onda M, Tajiri T, Yoshida H, Mamada Y, Taniai N, et al.
Reconstruction of the vena cava with the peritoneum. Am J Surg
2000;179:289-93.
14. Campbell JH, Efendy JL, Campbell GR. Novel vascular graft grown
within recipient’s own peritoneal cavity. Circ Res 1999;85:1173-8.
15. Maynar M, Qian Z, Hernandez J, Sun F, DeMiguel C, Cristomo V, et
al. An animal model of abdominal aortic aneurysm created with perito-
neal patch: technique and initial results. Cardiovasc Intervent Radiol
2003;26:168-76.
16. Magilligan DJ, Lewis JW, Stein P, Alan M. The porcine bioprosthetic
valce: experience at fifteen years. Ann Thor Surg 1989:48:324-30.
17. Sung HW, Chen CN, Huang RN, Hsu JC, ChangWH. In vitro surface
characterization of a biologic patch fixed with a naturally occurring
cross linking agent. Biomaterials 2000;21:1353-62.rat. Surg Res Comm 1987;2:43-57. Submitted Sep 12, 2004; accepted Nov 29, 2004.
COLLECTIONS OF PAPERS
On the Web version of the Journal, selected articles have been grouped together for the convenience of the
readers. The current collections include the following:
American Board of Vascular Surgery
Editorial Comments
History
Reporting Standards
Technical Notes
Basic Science Reviews
Guidelines
Lifeline Research Meeting Abstracts
Reviews
